Krystexxa 75987-0080-10
Generic: Pegloticase
- Manufacturer
- Horizon Therapeutics Usa, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 14, 2010
- Listing Expires
- December 31, 2027
- Application
- BLA125293
Need to source Krystexxa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pegloticase | 8 mg/mL |
Drug Class
Uric Acid-specific Enzyme [EPC]Urate Oxidase [CS]Uric Acid-specific Enzyme [EPC]
Selected Package
75987-0080-10Selected1 VIAL in 1 CARTON (75987-080-10) / 1 mL in 1 VIAL